O. Wilhelm et al., ANTISENSE INHIBITION OF UROKINASE REDUCES SPREAD OF HUMAN OVARIAN-CANCER IN MICE, Clinical & experimental metastasis, 13(4), 1995, pp. 296-302
Urokinase-type plasminogen activator (uPA) is a protease involved in t
he process of tissue remodelling and cell migration in vitro. To explo
re whether uPA is a prerequisite for human ovarian cancer spread in vi
vo the expression of uPA was suppressed in human ovarian cancer cells
by antisense phosphorothioate oligonucleotides (PS-ODN). The suppressi
on of uPA expression was dependent on PS-ODN concentration and only ob
served in the presence of liposomes. This phenomenon seemed to be due
to the fact that PS-ODNs were taken up by the cancer cells only in con
cert with liposomes as studied by fluorescently-labeled PS-ODNs using
flow cytofluorometry and laser scanning microscopy. uPA-deprived cance
r cells exhibited a significantly reduced invasive capacity in vitro c
ompared with untreated cancer cells or cells treated with control PS-O
DNs (P=0.003). The intraperitoneal spread of the cancer cells in vivo
was significantly diminished when nude mice were treated with uPA anti
sense PS-ODNs in comparison with control mice (P=0.009). These results
suggest that uPA expression may be required for spread of human ovari
an cancer and that its inhibition could provide a therapeutic approach
.